Bitopertin: all 28 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPEnrolling by invitationNCT05883748Phase 2/3
- Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan AnemiaCompletedNCT05828108Phase 1/2Results posted
- Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPPCompletedNCT05308472Phase 2Results posted
- Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at BaselineWithdrawnNCT07123363Phase 1
- Study of Bitopertin in Participants With EPP or XLP (APOLLO)CompletedNCT06910358Phase 3
- A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-ThalassemiaCompletedNCT03271541Phase 2
- A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.WithdrawnNCT02019290Phase 1
- A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)CompletedNCT01674361Phase 2
- A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy VolunteersCompletedNCT01665976Phase 1
- A Study of Bitopertin (RO4917838) in Healthy Male VolunteersCompletedNCT01636492Phase 1
- A Study of the Effect of RO4917838 on the QTcF Interval in Healthy VolunteersCompletedNCT01613040Phase 1
- A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy VolunteersCompletedNCT01543529Phase 1
- A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838CompletedNCT01510899Phase 1
- A Study on the Effects of Valproate on the Pharmacokinetics of RO4917838 in Healthy VolunteersCompletedNCT01495104Phase 1
- A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug UsersCompletedNCT01438749Phase 1
- A Pharmacokinetic Study of RO4917838 in Healthy Chinese VolunteersCompletedNCT01433575Phase 1
- A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy VolunteersCompletedNCT01365403Phase 1
- A Study on The Effect of Hepatic Impairment on The Pharmacokinetics of RO4917838CompletedNCT01356550Phase 1
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)CompletedNCT01235585Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)CompletedNCT01235559Phase 3
- A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)CompletedNCT01235520Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of SchizophreniaCompletedNCT01234779Phase 2
- A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)CompletedNCT01192906Phase 3
- A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of SchizophreniaCompletedNCT01192880Phase 3
- A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)CompletedNCT01192867Phase 3
- A Study of RO4917838 With Rosuvastatin in Healthy VolunteersCompletedNCT01183585Phase 1
- A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective DisorderCompletedNCT01116830Phase 1
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.CompletedNCT00616798Phase 2